FindTrial
Sign In

Effect of the number of lymph nodes examined and metastatic lymph node ratio on survival and staging in gastric cancer patients at pathological stage N3

Effect of the number of lymph nodes examined and metastatic lymph node ratio on survival and staging in gastric cancer patients at pathological stage N3

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084628
Enrollment
Unknown
Registered
2024-05-21
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

pathological N3 stage gastric cancer patients:Two group were produced according to the best cut-off value of lymph nodes examined

Sponsors

Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) 18-80 years old; (2) pathological stage N3 GC according to the AJCC TNM staging system, 8th edition; (3) histologically confirmed R0 resection, defined as no macroscopic or microscopic residual tumor; (4) no distant metastases or gastric-stump cancer; and (5) no other malignant tumors.

Exclusion criteria

Exclusion criteria: (1) patients who had undergone neoadjuvant chemotherapy or radiotherapy; (2) patients with insufficient information

Design outcomes

Primary

MeasureTime frame
Overall survival;Accuracy and reliability the new TNM staging system on prognosis prediction;—

Secondary

MeasureTime frame
Disease free survival;—

Countries

China

Contacts

Public ContactHongyu Zhang

The First Affiliated Hospital of Zhengzhou University

hongyuzhang624@hotmail.com+86 183 3920 6109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026